Ghisallo Capital Management »

Stoke Therapeutics shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $203k 15k 13.51
2024-03-31 $405k 30k 13.50

More positions owned by Ghisallo Capital Management

Diamondback Energy (FANG)
Dell Technologies CL C (DELL)
Ge Healthcare Technologies I Common Stock (GEHC)
Pinga 0.875 07/22/29 Convertible Bond (PIAIF)
Trip Com Group Ads (TCOM)
Lineage (LINE)
Viking Holdings Ord Shs (VIK)
Baba 0.500 06/01/31 Cvt Put Convertible Bond (Principal)
Hawaiian Electric Industries (HE)
Ul Solutions Class A Com Shs (ULS)
Palantir Technologies Cl A (PLTR)
Nasdaq Omx (NDAQ)
Pacs Group Com Shs (PACS)
Corebridge Finl (CRBG)
Posco Holdings Sponsored Adr (PKX)

View all positions for Ghisallo Capital Management

Top funds holding Stoke Therapeutics

Skorpios Trust
BlackRock
Lynx1 Capital Management
Rtw Investments
Baker Bros. Advisors
Redmile Group
Morgan Stanley
Toronto-Dominion Bank
Vanguard Group
State Street Corporation
Goldman Sachs Group
Assenagon Asset Management
Marshall Wace
Geode Capital Management
MPM Oncology Impact Management

View all funds holding Stoke Therapeutics